(Q36407318)

English

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

0 references

0 references

0 references

cannabinoid receptor

0 references

author name string

Eli V Gelfand

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Christopher P Cannon

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

307-315

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Current Smoking, Smoking Cessation, and the Risk of Sudden Cardiac Death in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Early and late weight gain following smoking cessation in the Lung Health Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Primary prevention of coronary heart disease in women through diet and lifestyle

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Production and physiological actions of anandamide in the vasculature of the rat kidney.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

A cannabinoid mechanism in relapse to cocaine seeking.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Rimonabant--a selective CB1 antagonist

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.3.307

21 January 2018

Identifiers

10.1517/13543784.15.3.307

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36407318&oldid=1629560386"